Author

Manishi Prasad

Observed name: M Prasad

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), United BioSource Corporation (United Kingdom)

OpenAlex ID: A5018094344

The Health-Related Quality of Life and Economic Burden of Constipation

2005 · Cheryl Dennison, Manishi Prasad, et al. · PharmacoEconomics · 391

A Review of Self-Report Instruments Measuring Health-Related Work Productivity

2004 · Manishi Prasad, Peter Wahlqvist, et al. · PharmacoEconomics · 327

A review of the economic burden of ADHD

2005 · Louis S Matza, Clark Paramore, et al. · Cost Effectiveness and Resource Allocation · 247

Cost-effectiveness of Evidence-Based Pharmacotherapy or Cognitive Behavior Therapy Compared With Community Referral for Major Depression in Predominantly Low-Income Minority Women

2005 · Dennis A. Revicki, Juned Siddique, et al. · Archives of General Psychiatry · 74

Cost of Invasive Fungal Infections in the Era of New Diagnostics and Expanded Treatment Options

2012 · Elizabeth Dodds Ashley, Richard Drew, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 64

The Impact of Treatment for Gastro-Oesophageal Reflux Disease on Health-Related Quality of Life

2003 · Manishi Prasad, Anne M Rentz, et al. · PharmacoEconomics · 49

The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: A microeconomic analysis

2002 · Ya-Chen Tina Shih, Manishi Prasad, et al. · Clinical Therapeutics · 39

Cost effectiveness of golimumab for the treatment of active psoriatic arthritis

2011 · Ewen Cummins, Christian Asseburg, et al. · The European Journal of Health Economics · 20

Adapting a global cost-effectiveness model to local country requirements: posaconazole case study

2012 · George Papadopoulos, Sheena Hunt, et al. · Journal of Medical Economics · 5

Psy38 Cost-effectiveness of Golimumab in Ankylosing Spondylitis From the Uk Payer Perspective

2010 · N Muszbek, Y Punekar, et al. · Value in Health · 1

Pms34 Cost-effectiveness of Golimumab in Psoriatic Arthritis From the Uk Payer Perspective

2010 · E Cummins, C Asseburg, et al. · Value in Health

Works count: 12

Citation count: 1,217

H-index: 8

I10-index: 8